Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Past, present and future of myoblast transplantation in the treatment of Duchenne muscular dystrophy.

Pediatric transplantation - 1 Nov 2010

Palmieri Beniamino, Tremblay Jacques P, Daniele Lodi

Abstract excerpt

DMD is a genetic X-linked recessive disease that affects approximately one in 3500 male births. Boys with DMD have progressive and predictable muscle destruction because of the absence of Dys, a protein present under the muscle fiber membrane. Dys deficiency induces contraction-related membrane damages, activation of inflammatory-necrosis-fibrosis up to the cardiac-diaphragmatic failure and death. This review...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Fibrosis
Share to Genetic Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunosuppressive Agents

Share to Muscle, Skeletal

Share to Muscular Dystrophy, Duchenne

Share to Myoblasts

Share to Necrosis

Source

Identifiers

PMID: 20963914
DOI: 10.1111/j.1399-3046.2010.01377.x

Genes

DMD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Past, present and future of myoblast transplantation in the treatment of Duchenne muscular dystrophy.PMID 20963914Read ↗

Myogenic Cell Transplantation in Genetic and Acquired Diseases of Skeletal MuscleSemantic proximity Read ↗

Cell therapy in muscular dystrophies: many promises in mice and dogs, few facts in patientsSemantic proximity Read ↗

Improving the therapeutic efficacy of gene therapy for duchenne muscular dystrophy (DMD) by evaluating and managing inflammationSemantic proximity Read ↗

Systemic cell therapy for muscular dystrophiesSemantic proximity Read ↗

Problems and solutions in myoblast transfer therapySemantic proximity Read ↗

Duchenne muscular dystrophy: current cell therapiesSemantic proximity Read ↗

Towards a Cure: Emerging Therapeutic Advances for DMD, LGMD, and GNEM- Insights from Pre-Clinical and Clinical ResearchSemantic proximity Read ↗

Current understanding of dystrophin-related muscular dystrophy and therapeutic challenges ahead.Semantic proximity Read ↗

Dental Pulp Stromal Cells Can Improve Muscle Dysfunction 1 in Animal Models of Duchenne Muscular DystrophySemantic proximity Read ↗

Co-Transplantation of Bone Marrow-MSCs and Myogenic Stem/Progenitor Cells from Adult Donors Improves Muscle Function of Patients with Duchenne Muscular Dystrophy.Semantic proximity Read ↗

Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future.Semantic proximity Read ↗

Molecular and cell-based therapies for muscle degenerations: a road under constructionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.